Counsel In $1.8B Biotech Sale Suit Urged To Work Together
By Rose Krebs (October 13, 2021, 8:42 PM EDT) -- Giving what he called "subtle, but not so subtle" advice, a Delaware vice chancellor on Wednesday urged counsel teams battling to lead stockholder litigation over the $1.8 billion sale of Emisphere Technologies Inc. to Novo Nordisk A/S to put aside differences and work together.
After a hearing during which two counsel teams made their case to lead the litigation, Vice Chancellor Joseph R. Slights III suggested the attorneys confer to see if they can agree to a leadership structure moving forward.
"This is an instance where collaboration would benefit the class," the vice chancellor said.
The vice chancellor told counsel to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!